相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni et al.
NATURE (2022)
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Tyler N. Starr et al.
SCIENCE (2022)
An alpaca single-domain antibody (VHH) phage display library constructed by CDR shuffling provided high-affinity VHHs against desired protein antigens
Narutoshi Tsukahara et al.
INTERNATIONAL IMMUNOLOGY (2022)
A guide to: generation and design of nanobodies
Serge Muyldermans
FEBS JOURNAL (2021)
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
The lightning-fast quest for COVID vaccines - and what it means for other diseases
Philip Ball
NATURE (2021)
Transition to endemicity: Understanding COVID-19
Rustom Antia et al.
IMMUNITY (2021)
Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2
Qilong Tang et al.
VIRUSES-BASEL (2021)
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
Fred D. Mast et al.
ELIFE (2021)
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
Hejun Liu et al.
CELL HOST & MICROBE (2021)
Immune response against SARS-CoV-2 variants: the role of neutralization assays
Alicja Maria Chmielewska et al.
NPJ VACCINES (2021)
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
Phillip Pymm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The story behind COVID-19 vaccines
Anthony S. Fauci
SCIENCE (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
Jianliang Xu et al.
NATURE (2021)
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Allison J. Greaney et al.
NATURE COMMUNICATIONS (2021)
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
Jennifer M. Zupancic et al.
CELL CHEMICAL BIOLOGY (2021)
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
Sham Nambulli et al.
SCIENCE ADVANCES (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe et al.
SCIENCE (2020)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
VIEWPOINT: COVID-19 Will SARS-CoV-2 become endemic?
Jeffrey Shaman et al.
SCIENCE (2020)
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Michael Schoof et al.
SCIENCE (2020)
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang et al.
SCIENCE (2020)
Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D
Suzanne S. Farid et al.
MABS (2020)
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity
Jianbo Dong et al.
EMERGING MICROBES & INFECTIONS (2020)
The Camel Adaptive Immune Receptors Repertoire as a Singular Example of Structural and Functional Genomics
Salvatrice Ciccarese et al.
FRONTIERS IN GENETICS (2019)
An improved yeast surface display platform for the screening of nanobody immune libraries
Tomasz Uchanski et al.
SCIENTIFIC REPORTS (2019)
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape
Lingshu Wang et al.
JOURNAL OF VIROLOGY (2018)
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Conor McMahon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Comparative analysis of nanobody sequence and structure data
Laura S. Mitchell et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2018)
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Conor McMahon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies
Uros Zavrtanik et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Integrative structure and functional anatomy of a nuclear pore complex
Seung Joong Kim et al.
NATURE (2018)
Nanobodies®† as inhaled biotherapeutics for lung diseases
Gino Van Heeke et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
Peter Bannas et al.
FRONTIERS IN IMMUNOLOGY (2017)
Optimizing selection of large animals for antibody production by screening immune response to standard vaccines
Mary K. Thompson et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies
Ema Romao et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes
Peter C. Fridy et al.
ANALYTICAL BIOCHEMISTRY (2015)
Emerging technologies in point-of-care molecular diagnostics for resource-limited settings
Rosanna W. Peeling et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
A robust pipeline for rapid production of versatile nanobody repertoires
Peter C. Fridy et al.
NATURE METHODS (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
An improved yeast transformation method for the generation of very large human antibody libraries
Lorenzo Benatuil et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Simple kinetic relationships and nonspecific competition govern nuclear import rates in vivo
Benjamin L. Timney et al.
JOURNAL OF CELL BIOLOGY (2006)
Selection, characterization, and CDR shuffling of naive llama single-domain antibodies selected against auxin and their cross-reactivity with auxinic herbicides from four chemical families
Claudia Sheedy et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Nanobodies as novel agents for cancer therapy
H Revets et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)